Atlas Trials

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

Clinical trial NCT06310369 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06310369
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2025-03-01
Primary completion
2025-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.